OrganoClick AB

OrganoClick AB TEMP's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, OrganoClick AB TEMP has 219.40M shares outstanding.

As of June 30, 2026, OrganoClick AB TEMP maintains a current ratio of 0.42, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 517.95, indicating elevated leverage, while an interest coverage ratio of -1.25 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, OrganoClick AB TEMP posted a negative return on equity (ROE) of -207.98, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -21.47, reflecting losses generated across the asset base. The company generates approximately 2.30M in revenue per employee across its workforce of 39.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.83 indicates how many times OrganoClick AB TEMP sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, OrganoClick AB TEMP recorded 70,000.00 in income tax expense. The company reported a pretax loss of -33.71M and -32.19M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended June 30, 2026, OrganoClick AB TEMP generated 90.28M in revenue and converted that into -32.19M in net income, yielding earnings per share of -0.26. EBITDA reached -9.00M, while operating income came in at -26.44M.

As of June 30, 2026, OrganoClick AB TEMP holds 480,000.00 in cash and equivalents against 78.56M in total debt, resulting in a net debt position of 52.57M. Total book value stands at 10.53M, with working capital of -59.05M providing operational flexibility.

OrganoClick AB TEMP produced -4.15M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -9.92M in capital expenditures, free cash flow totaled -14.07M - equivalent to -0.11 per share.

Over the twelve months ended June 30, 2026, OrganoClick AB TEMP posted a gross margin of 15.63, reflecting its pricing power and cost economics. The operating margin of -29.29 and net profit margin of -35.66 provide insight into operational efficiency.